Cargando…

Primary prevention of myocardial infarction: aspirin is not as useful as it seems

BACKGROUND: Aspirin has not been reliably shown to reduce all-cause and cardiovascular mortality but can prevent symptomatic myocardial infarction. However, silent myocardial infarction (SMI) is not uncommon in clinical practice. No meta-analysis has compared the effect of aspirin administration on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luan, Yi, Li, Ya, Zhao, Liding, Zhang, Wenbin, Fu, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186645/ https://www.ncbi.nlm.nih.gov/pubmed/32355805 http://dx.doi.org/10.21037/atm.2020.02.70

Ejemplares similares

Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020)

Gensini score values for predicting periprocedural myocardial infarction: An observational study analysis
por: Wang, Yao, et al.
Publicado: (2022)

Variability in blood lipids affects the neutrophil to lymphocyte ratio in patients undergoing elective percutaneous coronary intervention: a retrospective study
por: Zhao, Liding, et al.
Publicado: (2020)

Aspirin Use for the Primary Prevention of Myocardial Infarction Among Men in North Carolina, 2013
por: Tchwenko, Samuel, et al.
Publicado: (2015)

The influence of gender on the effects of aspirin in preventing myocardial infarction
por: Yerman, Todd, et al.
Publicado: (2007)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2020)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2022)

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors
por: Bugiardini, Raffaele, et al.
Publicado: (2020)

Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017)

Systemic Immune-Inflammation Index Predicts Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Cross-Sectional Study
por: Jiang, Hangpan, et al.
Publicado: (2022)

Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis
por: Li, Duanbin, et al.
Publicado: (2021)

Aspirin for primary prevention in the elderly
por: Saad, Marwan, et al.
Publicado: (2019)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Rosuvastatin Reverses Hypertension-Induced Changes in the Aorta Structure and Endothelium-Dependent Relaxation in Rats Through Suppression of Apoptosis and Inflammation
por: Lv, Qingbo, et al.
Publicado: (2020)

Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care
por: García Rodríguez, Luis A, et al.
Publicado: (2011)

Daylight saving time does not seem to be associated with number of percutaneous coronary interventions for acute myocardial infarction in the Netherlands
por: Derks, L., et al.
Publicado: (2021)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin in primary prevention: who is the target?
por: Gatto, Laura, et al.
Publicado: (2019)

Aspirin for primary prevention: Is this the end of the road?
por: Singal, Aayush Kumar, et al.
Publicado: (2019)

Aspirin in primary prevention: USPSTF recommendations
por: Aalbers, J
Publicado: (2010)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Predictive value of baseline C-reactive protein for periprocedural myocardial infraction of higher risk stratifications: A retrospective cohort clinical study
por: Yao, Mingyang, et al.
Publicado: (2018)

Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction
por: Enhos, Asim, et al.
Publicado: (2021)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction
por: Lv, Qingbo, et al.
Publicado: (2022)

Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ(1) signaling pathway in diabetic atherosclerosis
por: Zhao, Liding, et al.
Publicado: (2022)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for Primary Prevention: A Challenging Decision
por: Pignone, Michael
Publicado: (2014)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Not everything is as it seems
por: Biyani, Ghansham, et al.
Publicado: (2020)

Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
por: Borna, Catharina, et al.
Publicado: (2005)

Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction
por: Pandey, Chandra Prakash, et al.
Publicado: (2019)

Admission electrolyte and osmotic pressure levels are associated with the incidence of contrast-associated acute kidney injury
por: Lv, Qingbo, et al.
Publicado: (2022)

Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial
por: Li, Zhengwei, et al.
Publicado: (2022)

A detailed analysis of patients included in the Summary Hospital-level Mortality Indicator (SHMI) for myocardial infarction (MI)—all is not what it seems?
por: Sharma, Vinoda, et al.
Publicado: (2020)

Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial
por: Li, Zhanlu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqfqj892tcpunvej040gr2qr1j